Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take…
Official title: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors … Show full official titleShow less
Official title: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H. Con. Res. 42: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.. 117th Congress. Open America. https://openamerica.io/bill/117-HCONRES-42/
"H. Con. Res. 42: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HCONRES-42/.
H. Con. Res. 42, 117th Cong. (2026), https://openamerica.io/bill/117-HCONRES-42/.
[H. Con. Res. 42: Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.](https://openamerica.io/bill/117-HCONRES-42/)